by Clinical Neuropsychologist Online | Thursday, July 9, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 9, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Thursday, July 9, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 9, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Thursday, July 9, 2026 | Dementia
Dementia, Ahead of Print. Family caregivers of persons with dementia often face chronic stress, disrupted sleep, and emotional exhaustion. While adult day programs provide daytime respite, support during nighttime, when caregiving responsibilities can intensify,...
by Clinical Neuropsychologist Online | Thursday, July 9, 2026 | Dementia
Abstract INTRODUCTION Alzheimer’s disease involves trans-synaptic spread of tau pathology from temporal lobe epicenters, driven by amyloid beta (Aβ) deposition. How modular brain network architecture shapes this process and the ensuing cognitive decline remains...
by Clinical Neuropsychologist Online | Thursday, July 9, 2026 | Dementia
Abstract INTRODUCTION Lecanemab, the first disease-modifying therapy for Alzheimer’s disease (AD), mitigates pathology primarily by clearing amyloid plaques, but its impact on peripheral immunity remains unclear. METHODS To assess Lecanemab’s immunological...
